Cadila launches generic versions of type 2 diabetes drug Sitagliptin in India

Sitagliptin has a strong clinical profile and the potential to revolutionise the treatment of type 2 diabetes for millions of people who do not achieve the targeted blood sugar level with currently available anti-diabetic medications. Cadila Pharmaceuticals has launched the generic versions of Sitagliptin in India under the brand names Jankey & Sitenali to address type 2 diabetes. Sitagliptin is a drug from the class of DPP-4 inhibitors, and a one-ofits-kind drug for the treatment of high glucose levels in the blood, also known as hyperglycaemia. High blood glucose can lead to such as atherosclerosis, stroke, heart attack, retinopathy, neuropathy and nephropathy. According to a recently published report, approximately 7.7 core people in India are suffering from diabetes. Metformin is presently the drug of choice for controlling blood glucose levels, but in the majority of the patients, it either does not provide optimum control or is not tolerated. Cadila has made a foray into the diabetes care segment with the launch of Sitenali and Jankey, having cardio-safe gliptin sitagliptin. It has also launched a potent combination of Sitagliptin and Metformin and branded it as Jankey M.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!